| Bacterial Infections and Vaccines | Lifetime | 4 | GB 2 | 99.83 |
| Pneumonia and Respiratory Infections | Lifetime | 15 | GB 1 | 99.86 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 48 | GB 2 | 99.72 |
| Vaccine Coverage and Hesitancy | Lifetime | 44 | GB 4 | 99.37 |
| Respiratory viral infections research | Lifetime | 94 | GB 10 | 99.51 |
| Viral gastroenteritis research and epidemiology | Lifetime | 126 | GB 6 | 99.45 |
| COVID-19 Clinical Research Studies | Lifetime | 209 | GB 20 | 98.98 |
| Influenza Virus Research Studies | Lifetime | 88 | GB 10 | 99.40 |
| Salmonella and Campylobacter epidemiology | Lifetime | 154 | GB 19 | 98.93 |
| Immune responses and vaccinations | Lifetime | 74 | GB 10 | 97.08 |
| Vibrio bacteria research studies | Lifetime | 296 | GB 23 | 97.82 |
| Virology and Viral Diseases | Lifetime | 492 | GB 50 | 96.40 |
| Teacher Education and Leadership Studies | Lifetime | 549 | GB 64 | 96.16 |
| Viral Infections and Outbreaks Research | Lifetime | 615 | GB 57 | 94.97 |
| High Altitude and Hypoxia | Lifetime | 516 | GB 53 | 94.36 |
| Education Systems and Policy | Lifetime | 815 | GB 165 | 94.85 |
| Infectious Encephalopathies and Encephalitis | Lifetime | 269 | GB 19 | 92.34 |
| Reflective Practices in Education | Lifetime | 409 | GB 86 | 93.18 |
| Student Assessment and Feedback | Lifetime | 222 | GB 43 | 93.89 |
| Neonatal and Maternal Infections | Lifetime | 682 | GB 51 | 91.41 |
| Higher Education Learning Practices | Lifetime | 874 | GB 171 | 86.90 |
| Educator Training and Historical Pedagogy | Lifetime | 989 | GB 110 | 87.26 |
| Travel-related health issues | Lifetime | 736 | GB 83 | 81.85 |
| Global Educational Policies and Reforms | Lifetime | 678 | GB 187 | 84.48 |
| Intramuscular injections and effects | Lifetime | 422 | GB 36 | 76.98 |
| Innovative Education and Learning Practices | Lifetime | 947 | GB 229 | 71.72 |
| Educational Theory and Curriculum Studies | Lifetime | 254 | GB 71 | 43.87 |
| Viral gastroenteritis research and epidemiology | 2021-2025 | 10 | GB 1 | 99.32 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 100 | GB 11 | 99.48 |
| Respiratory viral infections research | 2021-2025 | 39 | GB 4 | 98.84 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 87 | GB 9 | 98.32 |
| Salmonella and Campylobacter epidemiology | 2021-2025 | 50 | GB 6 | 96.64 |
| COVID-19 Clinical Research Studies | 2021-2025 | 933 | GB 104 | 96.25 |
| Pneumonia and Respiratory Infections | 2021-2025 | 212 | GB 25 | 95.35 |
| Bacterial Infections and Vaccines | 2021-2025 | 208 | GB 32 | 88.81 |
| Vibrio bacteria research studies | 2021-2025 | 334 | GB 20 | 87.29 |
| Viral Infections and Outbreaks Research | 2021-2025 | 450 | GB 54 | 86.45 |
| Congenital Diaphragmatic Hernia Studies | 2021-2025 | 473 | GB 27 | 86.10 |
| COVID-19 Impact on Reproduction | 2021-2025 | 759 | GB 58 | 83.47 |
| Influenza Virus Research Studies | 2021-2025 | 928 | GB 61 | 85.05 |
| Escherichia coli research studies | 2021-2025 | 311 | GB 19 | 81.30 |
| vaccines and immunoinformatics approaches | 2021-2025 | 873 | GB 46 | 74.58 |